Angiogenin and hemoxygenase in pregnancy: Influence of hypertension

Angiology

Volumn 63, Issue 3, 2012, Pages 194-198

  Karthikeyan, Velore J ^a   Lip, Gregory Y H ^a   Baghdadi, Sabah ^b   Lane, Deirdre A ^a   Beevers, D Gareth ^a   Blann, Andrew D ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

angiogenesis; angiogenin; endothelium; hemoxygenase; hypertension in pregnancy; vascular endothelial growth factor; von Willebrand factor

Indexed keywords

ANGIOGENIN; HEME OXYGENASE 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MATERNAL HYPERTENSION; PATHOPHYSIOLOGY; PREGNANT WOMAN; PROTEIN BLOOD LEVEL;

ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEME OXYGENASE-1; HUMANS; HYPERTENSION; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RIBONUCLEASE, PANCREATIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 84857834201     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319711410308     Document Type: Article

References (40)

1. Hypertension in Pregnancy. ACOG Technical Bulletin No.: 219. Washington, DC: The College ; 1996: 1-8.
2. Hutcheon JA, Lisonkova S, Joseph KS.. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011 ;:
3. Jim B, Sharma S, Kebede T, Acharya A.. Hypertension in pregnancy: a comprehensive update. Cardiol Rev. 2010 ; 18 (4). 178-189
4. Sibai BM, Koch MA, Freire S, et al. The impact of prior preeclampsia on the risk of superimposed preeclampsia and other adverse pregnancy outcomes in patients with chronic hypertension. Am J Obstet Gynecol. 2011 ; 204 (4). 345.e1-6
5. Flenady V, Koopmans L, Middleton P, et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet. 2011 ; 377 (9774). 1331-1340
6. Sheppard SJ, Khalil RA.. Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy. Cardiovasc Hematol Disord Drug Targets. 2010 ; 10 (1). 33-52
7. Germain AM, Romanik MC, Guerra I, et al. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?. Hypertension. 2007 ; 49 (1). 90-95 (Pubitemid 46360346)
8. Myatt L, Webster RP.. Vascular biology of preeclampsia. J Thromb Haemost. 2009 ; 7 (3). 375-384
9. Foidart JM, Schaaps JP, Chantraine F, Munaut C, Lorquet S.. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia-a step forward but not the definitive answer. J Reprod Immunol. 2009 ; 82 (2). 106-111
10. Hayman R, Brockelsby J, Kenny L, Baker P.. Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor. J Soc Gynecol Investig. 1999 ; 6 (1). 3-10 (Pubitemid 29093399)
11. Baker PN, Krasnow J, Roberts JM, Yeo KT.. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol. 1995 ; 86 (5). 815-821
12. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004 ; 350 (7). 672-683 (Pubitemid 38364626)
13. Kolben H, Bläser J, Ulm K, et al. Angiogenin plasma levels during pregnancy. Am J Obstet Gynecol. 1997 ; 176 (1 pt 1). 37-41 (Pubitemid 127780744)
14. Reuvekamp A, Velsing-Aarts FV, Poulina IE, Capello JJ, Duits AJ.. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol. 1999 ; 106 (10). 1019-1022 (Pubitemid 29457082)
15. Shaarawy M, Al-Sokkary F, Sheba M, Wahba O, Kandil HO, Abdel-Mohsen I.. Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia. Int J Gynaecol Obstet. 2005 ; 88 (2). 112-117 (Pubitemid 40247495)
16. Sane DC, Anton L, Brosnihan KB.. Angiogenic growth factors and hypertension. Angiogenesis. 2004 ; 7 (3). 193-201
17. Nadar SK, Karalis I, Al Yemeni E, Blann AD, Lip GY.. Plasma markers of angiogenesis in pregnancy induced hypertension. Thromb Haemost. 2005 ; 94 (5). 1071-1076 (Pubitemid 41645951)
18. Belgore FM, Blann AD, Li-Saw-Hee FL, Beevers DG, Lip GY.. Plasma levels of vascular endothelial growth factor and its soluble receptor (sFlt-1) in essential hypertension. Am J Cardiol. 2001 ; 87 (6). 805-807 (Pubitemid 32209107)
19. Chen YH, Yet SF, Perrella MA.. Role of heme oxygenase-1 in the regulation of blood pressure and cardiac function. Exp Biol Med. 2003 ; 228 (5). 447-453 (Pubitemid 37203658)
20. Cao J, Inoue K, Li X, Drummond G, Abraham NG.. Physiological significance of heme oxygenase in hypertension. Int J Biochem Cell Biol. 2009 ; 41 (5). 1025-1033
21. Dulak J, Józkowicz A, Foresti R, et al. Heme oxygenase activity modulates VEGF synthesis in vascular smooth muscle cells. Antioxid Redox Signal. 2002 ; 4 (2). 229-240 (Pubitemid 34517174)
22. Bussolati B, Ahmed A, Pemberton H, et al. Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood. 2004 ; 103 (3). 761-766 (Pubitemid 38129530)
23. Dulak J, Deshane J, Jozkowicz A, Agarwal A.. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation. 2008 ; 117 (2). 231-241
24. Cudmore M, Ahmad S, Al-Ani B, et al. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation. 2007 ; 115 (13). 1789-1797 (Pubitemid 46648616)
25. Ahmed A, Cudmore MJ.. Can the biology of VEGF and haem oxygenases help solve pre-eclampsia?. Biochem Soc Trans. 2009 ; 37 (pt 6). 1237-1242
26. Bainbridge SA, Smith GN.. HO in pregnancy. Free Radic Biol Med. 2005 ; 38 (8). 979-988 (Pubitemid 40386544)
27. Blann AD.. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years. Thromb Haemost. 2006 ; 95 (1). 49-55
28. Stirling Y, Woolf L, North WR, Seghatchian MJ, Meade TW.. Haemostasis in normal pregnancy. Thromb Haemost. 1984 ; 52 (2). 176-182 (Pubitemid 14024007)
29. Nadar SK, Al Yemeni E, Blann AD, Lip GYH.. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension. Thromb Res. 2004 ; 113 (2). 123-128 (Pubitemid 38534489)
30. Ogawa T, Suzuki Y, Sayama S, Soma H.. Possible relationship between the ratio of Factor VIII complex and placental insufficiency in preeclampsia. Biol Res Pregnancy Perinatol. 1983 ; 4 (4). 155-157 (Pubitemid 14214116)
31. Molvarec A, Rigó Jr J, Bõze T, et al. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia. Thromb Haemost. 2009 ; 101 (2). 305-311
32. Tello-Montoliu A, Patel JV, Lip GYH.. Angiogenin: a review of the pathophysiology and potential clinical applications. J Thromb Haemost. 2006 ; 4 (9). 1864-1874 (Pubitemid 44226759)
33. Lyall F, Barber A, Myatt L, Bulmer JN, Robson SC.. Hemeoxygenase expression in human placenta and placental bed implies a role in regulation of trophoblast invasion and placental function. FASEB J. 2000 ; 14 (1). 208-219 (Pubitemid 30051538)
34. Ali KZ, Burton GJ, Khalid ME, Moosa R, Abd-Alla S.. Concentrations of free vascular endothelial growth factor in the maternal and foetal circulations during pregnancy: a cross-sectional study. J Matern Fetal Neonatal Med. 2010 ; 23 (10). 1244-1248
35. Blann AD, Naqvi T, Waite M, McCollum CN.. von Willebrand factor and endothelial cell damage in essential hypertension. J Human Hyperten. 1993 ; 7 (2). 107-111 (Pubitemid 23138184)
36. Idriss KR, Lip GYH, Balakrishnan B, Jaumdally R, Boos CJ, Blann AD.. Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor. Thromb Haemost. 2010 ; 104 (5). 1029-1037
37. Bao W, Song F, Li X, et al. Plasma heme oxygenase-1 concentration is elevated in individuals with type 2 diabetes mellitus. PLoS One. 2010 ; 5 (8). e12371
38. Zhao H, Wong RJ, Kalish FS, Nayak NR, Stevenson DK.. Effect of heme oxygenase-1 deficiency on placental development. Placenta. 2009 ; 30 (10). 861-868
39. McCaig D, Lyall F.. Heme oxygenase expression in human placental villous tissue in response to exposure to in vitro ischemia-reperfusion injury. Hypertens Pregnancy. 2009 ; 28 (3). 256-272
40. Ahmed A.. New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications. Thromb Res. 2011 ; 127 (suppl 3). S72 - S75